Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 376

1.

Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants.

Madeleine MM, Carter JJ, Johnson LG, Wipf GC, Davis C, Berg D, Nelson K, Daling JR, Schwartz SM, Galloway DA.

Cancer Med. 2014 Oct;3(5):1440-7. doi: 10.1002/cam4.280. Epub 2014 Jun 10.

2.

Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.

Li CI, Daling JR, Haugen KL, Tang MT, Porter PL, Malone KE.

Breast Cancer Res Treat. 2014 Jun;145(2):481-9. doi: 10.1007/s10549-014-2960-4. Epub 2014 Apr 20.

3.

Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.

Beaber EF, Malone KE, Tang MT, Barlow WE, Porter PL, Daling JR, Li CI.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):755-64. doi: 10.1158/1055-9965.EPI-13-0944. Epub 2014 Mar 14.

4.

Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years.

Li CI, Daling JR, Tang MT, Haugen KL, Porter PL, Malone KE.

JAMA Intern Med. 2013 Sep 23;173(17):1629-37. doi: 10.1001/jamainternmed.2013.9071.

5.

Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age.

McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1529-37. doi: 10.1158/1055-9965.EPI-13-0414. Epub 2013 Jul 5.

6.

Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.

Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR, Malkki M, Petersdorf EW, Schwartz SM.

Int J Cancer. 2013 Jul;133(1):201-13. doi: 10.1002/ijc.28000. Epub 2013 Feb 12.

7.

Use of antihypertensive medications and breast cancer risk.

Saltzman BS, Weiss NS, Sieh W, Fitzpatrick AL, McTiernan A, Daling JR, Li CI.

Cancer Causes Control. 2013 Feb;24(2):365-71. doi: 10.1007/s10552-012-0122-8. Epub 2012 Dec 8.

PMID:
23224328
8.

Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.

Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE.

Breast Cancer Res Treat. 2013 Jan;137(2):579-87. doi: 10.1007/s10549-012-2365-1. Epub 2012 Dec 9.

9.

Cohort profile: the skin cancer after organ transplant study.

Madeleine MM, Johnson LG, Daling JR, Schwartz SM, Carter JJ, Berg D, Nelson K, Davis CL, Galloway DA.

Int J Epidemiol. 2013 Dec;42(6):1669-77. doi: 10.1093/ije/dys179. Epub 2012 Nov 21.

10.

Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.

Saltzman BS, Malone KE, McDougall JA, Daling JR, Li CI.

Breast Cancer Res Treat. 2012 Oct;135(3):849-55. doi: 10.1007/s10549-012-2183-5. Epub 2012 Aug 19.

11.

Estrogen-related genes and their contribution to racial differences in breast cancer risk.

Reding KW, Chen C, Lowe K, Doody DR, Carlson CS, Chen CT, Houck J, Weiss LK, Marchbanks PA, Bernstein L, Spirtas R, McDonald JA, Strom BL, Burkman RT, Simon MS, Liff JM, Daling JR, Malone KE.

Cancer Causes Control. 2012 May;23(5):671-81. doi: 10.1007/s10552-012-9925-x. Epub 2012 Mar 15.

12.

Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age.

Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE.

Cancer Res. 2012 Apr 15;72(8):2028-35. doi: 10.1158/0008-5472.CAN-11-4064. Epub 2012 Feb 27.

13.

Oral contraceptive formulation and risk of breast cancer.

Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, McDonald JA, Daling JR, Bernstein L, Malone KE, Wingo PA, Simon MS, Norman SA, Strom BL, Ursin G, Weiss LK, Burkman RT, Spirtas R.

Contraception. 2012 Apr;85(4):342-50. doi: 10.1016/j.contraception.2011.08.007. Epub 2011 Sep 28.

14.

Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancer.

Malone KE, Daling JR, Doody DR, O'Brien C, Resler A, Ostrander EA, Porter PL.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2560-71. doi: 10.1158/1055-9965.EPI-11-0781. Epub 2011 Sep 29.

15.

Relationship between menopausal symptoms and risk of postmenopausal breast cancer.

Huang Y, Malone KE, Cushing-Haugen KL, Daling JR, Li CI.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):379-88. doi: 10.1158/1055-9965.EPI-10-0998. Epub 2011 Jan 6.

16.

Smoking during first pregnancy and breast cancer: a case-control study using Washington State registry data.

DeRoo LA, Cummings P, Daling JR, Mueller BA.

Ann Epidemiol. 2011 Jan;21(1):53-5. doi: 10.1016/j.annepidem.2010.09.004.

17.

Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer.

Reding KW, Doody DR, McTiernan A, Hsu L, Davis S, Daling JR, Porter PL, Malone KE.

Breast Cancer Res Treat. 2011 Apr;126(3):749-61. doi: 10.1007/s10549-010-1174-7. Epub 2010 Sep 29.

18.

Relationship between diabetes and risk of second primary contralateral breast cancer.

Li CI, Daling JR, Tang MT, Malone KE.

Breast Cancer Res Treat. 2011 Jan;125(2):545-51. doi: 10.1007/s10549-010-1035-4. Epub 2010 Jul 13.

19.

Infertility treatment use in relation to selected adverse birth outcomes.

Welmerink DB, Voigt LF, Daling JR, Mueller BA.

Fertil Steril. 2010 Dec;94(7):2580-6. doi: 10.1016/j.fertnstert.2010.03.005.

PMID:
20434152
20.

Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk.

Reding KW, Li CI, Weiss NS, Chen C, Carlson CS, Duggan D, Thummel KE, Daling JR, Malone KE.

Am J Epidemiol. 2009 Nov 15;170(10):1241-9. doi: 10.1093/aje/kwp298. Epub 2009 Oct 21.

21.

Reproductive outcomes in male childhood cancer survivors: a linked cancer-birth registry analysis.

Chow EJ, Kamineni A, Daling JR, Fraser A, Wiggins CL, Mineau GP, Hamre MR, Severson RK, Drews-Botsch C, Mueller BA.

Arch Pediatr Adolesc Med. 2009 Oct;163(10):887-94. doi: 10.1001/archpediatrics.2009.111.

22.

Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis.

Mueller BA, Chow EJ, Kamineni A, Daling JR, Fraser A, Wiggins CL, Mineau GP, Hamre MR, Severson RK, Drews-Botsch C.

Arch Pediatr Adolesc Med. 2009 Oct;163(10):879-86. doi: 10.1001/archpediatrics.2009.112.

23.

Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study.

Maley SN, Schwartz SM, Johnson LG, Malkki M, Du Q, Daling JR, Li SS, Zhao LP, Petersdorf EW, Madeleine MM.

Int J Immunogenet. 2009 Dec;36(6):367-75. doi: 10.1111/j.1744-313X.2009.00877.x. Epub 2009 Sep 24.

24.

Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer.

Li CI, Daling JR, Porter PL, Tang MT, Malone KE.

J Clin Oncol. 2009 Nov 10;27(32):5312-8. doi: 10.1200/JCO.2009.23.1597. Epub 2009 Sep 8.

25.

Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer.

Li CI, Daling JR, Porter PL, Tang MT, Malone KE.

Cancer Res. 2009 Sep 1;69(17):6865-70. doi: 10.1158/0008-5472.CAN-09-1355. Epub 2009 Aug 25. Erratum in: Cancer Res. 2010 Mar 1;70(5):2140. Cancer Res. 2010 Jan 15;70(2):853.

26.

Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women.

Li CI, Mathes RW, Malone KE, Daling JR, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Deapen D, Burkman RT, Folger SG, McDonald JA, Spirtas R.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2030-4. doi: 10.1158/1055-9965.EPI-09-0291.

27.

Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.

Reding KW, Weiss NS, Chen C, Li CI, Carlson CS, Wilkerson HW, Farin FM, Thummel KE, Daling JR, Malone KE.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1461-7. doi: 10.1158/1055-9965.EPI-08-0917. Epub 2009 Apr 21.

28.

Risk factors for triple-negative breast cancer in women under the age of 45 years.

Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, Malone KE.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1157-66. doi: 10.1158/1055-9965.EPI-08-1005. Epub 2009 Mar 31.

29.

Association of marijuana use and the incidence of testicular germ cell tumors.

Daling JR, Doody DR, Sun X, Trabert BL, Weiss NS, Chen C, Biggs ML, Starr JR, Dey SK, Schwartz SM.

Cancer. 2009 Mar 15;115(6):1215-23. doi: 10.1002/cncr.24159.

30.

Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer.

Beaber EF, Holt VL, Malone KE, Porter PL, Daling JR, Li CI.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3427-34. doi: 10.1158/1055-9965.EPI-08-0641. Erratum in: Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3138.

31.

Migraine in postmenopausal women and the risk of invasive breast cancer.

Mathes RW, Malone KE, Daling JR, Davis S, Lucas SM, Porter PL, Li CI.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3116-22. doi: 10.1158/1055-9965.EPI-08-0527.

32.

Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.

Phipps AI, Malone KE, Porter PL, Daling JR, Li CI.

Cancer. 2008 Oct 1;113(7):1521-6. doi: 10.1002/cncr.23786.

33.

Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.

Loo LW, Ton C, Wang YW, Grove DI, Bouzek H, Vartanian N, Lin MG, Yuan X, Lawton TL, Daling JR, Malone KE, Li CI, Hsu L, Porter PL.

Genes Chromosomes Cancer. 2008 Dec;47(12):1049-66. doi: 10.1002/gcc.20610.

34.

Effect of prediagnostic alcohol consumption on survival after breast cancer in young women.

Reding KW, Daling JR, Doody DR, O'Brien CA, Porter PL, Malone KE.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1988-96. doi: 10.1158/1055-9965.EPI-07-2897. Epub 2008 Jul 29.

35.

Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women.

Phipps AI, Malone KE, Porter PL, Daling JR, Li CI.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2078-86. doi: 10.1158/1055-9965.EPI-08-0206. Epub 2008 Jul 29.

36.

Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.

Hussain SK, Madeleine MM, Johnson LG, Du Q, Malkki M, Wilkerson HW, Farin FM, Carter JJ, Galloway DA, Daling JR, Petersdorf EW, Schwartz SM.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1790-9. doi: 10.1158/1055-9965.EPI-07-2753.

37.

Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk.

Madeleine MM, Johnson LG, Smith AG, Hansen JA, Nisperos BB, Li S, Zhao LP, Daling JR, Schwartz SM, Galloway DA.

Cancer Res. 2008 May 1;68(9):3532-9. doi: 10.1158/0008-5472.CAN-07-6471.

38.

Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer.

Mathes RW, Malone KE, Daling JR, Porter PL, Li CI.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):67-72. doi: 10.1158/1055-9965.EPI-07-0765.

39.

Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.

Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):43-50. doi: 10.1158/1055-9965.EPI-07-0558. Erratum in: Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2803.

40.
41.

Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women.

Trabert B, Malone KE, Daling JR, Doody DR, Bernstein L, Ursin G, Marchbanks PA, Strom BL, Humphrey MC, Ostrander EA.

Breast Cancer Res. 2007;9(6):R84.

42.

Timing of menarche and first full-term birth in relation to breast cancer risk.

Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Ursin G, Burkman RT, Folger SG, Norman S, McDonald JA, Spirtas R.

Am J Epidemiol. 2008 Jan 15;167(2):230-9. Epub 2007 Oct 26.

43.

The association between oral contraceptive use and lobular and ductal breast cancer in young women.

Nyante SJ, Gammon MD, Malone KE, Daling JR, Brinton LA.

Int J Cancer. 2008 Feb 15;122(4):936-41.

44.

Validity of models for predicting BRCA1 and BRCA2 mutations.

Parmigiani G, Chen S, Iversen ES Jr, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis L, Tomlinson G, Amos CI, Strong LC, Berry DA, Weitzel JN, Sand S, Dutson D, Kerber R, Peshkin BN, Euhus DM.

Ann Intern Med. 2007 Oct 2;147(7):441-50.

45.

Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003.

McDougall JA, Madeleine MM, Daling JR, Li CI.

Cancer Causes Control. 2007 Dec;18(10):1175-86. Epub 2007 Sep 6.

PMID:
17805982
46.

Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study.

Knight JA, Lesosky M, Blackmore KM, Voigt LF, Holt VL, Bernstein L, Marchbanks PA, Burkman RT, Daling JR, Whittemore AS.

Breast Cancer Res Treat. 2008 May;109(1):157-64. Epub 2007 Jul 7.

PMID:
17616808
47.

Risk of anogenital cancer in women with CIN.

Daling JR.

Lancet Oncol. 2007 Apr;8(4):281-2. No abstract available.

PMID:
17395100
48.

Statin use and breast cancer risk in a large population-based setting.

Boudreau DM, Yu O, Miglioretti DL, Buist DS, Heckbert SR, Daling JR.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):416-21.

49.

Risk of breast cancer associated with short-term use of oral contraceptives.

Folger SG, Marchbanks PA, McDonald JA, Bernstein L, Ursin G, Berlin JA, Daling JR, Norman SA, Strom BL, Weiss LK, Simon MS, Burkman RT, Malone KE, Spirtas R.

Cancer Causes Control. 2007 Mar;18(2):189-98. Epub 2007 Jan 10.

PMID:
17216547
50.

Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.

Madeleine MM, Anttila T, Schwartz SM, Saikku P, Leinonen M, Carter JJ, Wurscher M, Johnson LG, Galloway DA, Daling JR.

Int J Cancer. 2007 Feb 1;120(3):650-5.

Supplemental Content

Loading ...
Support Center